Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
240.00    5.00 (2.13%)
Bid:
235.00
Ask:
245.00
Spread: 10.00 (4.255%)
Market Cap: £86.30m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Trading Statement

23 Jul 2020 07:00

RNS Number : 8120T
Alumasc Group PLC
23 July 2020
 

23 July 2020

 

THE ALUMASC GROUP PLC

("ALUMASC")

Trading Statement

June sales significantly ahead of internal forecasts

Alumasc, the premium building products, systems and solutions group, provides the following update on trading. The financial year to 30 June 2020 ended with improving trading, with sales in the second half of May and during June significantly ahead of internal forecasts made earlier in the pandemic. Revenue for the year ended 30 June 2020 is now expected to be approximately £76m a decrease of c.16% on the previous year almost entirely as a result of the COVID-19 lockdown, with the bulk of the impact felt during late March, April and early May.

Our primary focus continues to be the safety and wellbeing of our employees, suppliers and customers. Alumasc's health and safety practices follow UK Government guidelines at all our sites in terms of being COVID-19 secure.

FY2020 and current trading

Despite the adverse impact of the reduced revenue, profitability has benefitted from internal initiatives to reduce costs, as advised in previous announcements. Prior to the outbreak of the COVID-19 pandemic Alumasc was already in the process of implementing a cost saving programme focussed on realising synergies available following the acquisition of Wade, together with other operational efficiencies and improvements. Subsequent to the lockdown this process was accelerated, and further actions were taken, including the reduction of all non-essential expenditure, a freeze on all non-essential recruitment and a redoubling of our efforts around working capital resulting. All actions combined generated total cost savings of £2.4m compared to the prior financial year.

Encouragingly, improved levels of trading have continued into July, and all sites and manufacturing locations are now fully operational. Each location has implemented appropriate social distancing requirements without any loss of productivity.

Order intake has matched the general pick-up in construction activity and inquiry levels continue to be strong both in the UK and from the Group's targeted overseas markets. There has also been increased interest in the Group's premium and sustainable product range, which is well positioned to benefit from the UK Government's announced planned expenditure on a wide range of infrastructure and public sector construction projects.

Balance sheet and liquidity

As at 30 June 2020, the Group had net debt of £4.3m (compared to £5.1m at 30 June 2019). This is comfortably ahead of management's expectations as at the start of the final quarter once lockdown started, with leverage and interest cover metrics at 30 June 2020 well within covenant limits, reflecting the encouraging recent trading performance and effective working capital focus. The Company has also benefitted from a VAT deferral.

Group liquidity is strong with £15.7m cash held at 30 June 2020, following the draw down of the RCF. The Group's total bank facilities are £24m, comprising the committed RCF of £20m and overdraft facilities of £4m. Hence the Group had headroom of £19.7m against its total banking facilities at 30 June 2020.

Outlook

Trading has been better than management expected at the outset of COVID-19 and continues to show an improving trend, despite the challenging environment.

Alumasc's cost savings programme, liquidity management, strong balance sheet and improved commercial positioning underpin a robust platform that should greatly benefit the Group into a broader economic recovery when it materialises. Alumasc's primary aim is to manage the long-term sustainability of the business and to focus on its key strategic objectives, growing revenues faster than the UK construction market and being a supplier of sustainable building products.

Alumasc expects to release its preliminary results in September 2020. Given the uncertain economic backdrop, financial guidance remains suspended at present, and the Board will provide an update in September 2020.

 

This announcement contains inside information for the purposes of Market Abuse Regulation (Regulation (EU) No. 596/2014). The person responsible for making this announcement on behalf of the Company is Helen Ashton, Group Company Secretary.

 

Enquiries:

 

Paul Hooper, CEO

Helen Ashton, Group Company Secretary

 

+ 44 (0) 1536 383844

+ 44 (0) 1536 383812

 

Peel Hunt (Broker)

Mike Bell + 44 (0) 207 418 8831

Ed Allsopp

 

finnCap (NOMAD)

Julian Blunt + 44 (0) 207 220 0561

Camarco

Ginny Pulbrook + 44 (0) 203 757 4992

Tom Huddart + 44 (0) 203 757 4991

Email: alumasc@camarco.co.uk

 

Notes to Editors:

Alumasc is a UK-based supplier of premium building products, systems and solutions. Almost 80% of group sales are driven by building regulations and specifications (architects and structural engineers) because of the performance characteristics offered.

 

The Group has three business segments with strong positions and brands in their individual markets. The three segments are: Building Envelope; Water Management; and Housebuilding Products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFVRDFIFFII
Date   Source Headline
4th May 20163:31 pmRNSHolding(s) in Company
21st Mar 20162:35 pmRNSDirector/PDMR Shareholding
9th Mar 20169:38 amRNSHolding(s) in Company
7th Mar 20164:22 pmRNSDirector/PDMR Shareholding
2nd Feb 20167:00 amRNSHalf Yearly Report
8th Jan 20167:00 amRNSNotice of Results
10th Dec 20153:53 pmRNSDirector/PDMR Shareholding
11th Nov 20153:16 pmRNSHolding(s) in Company
23rd Oct 20153:07 pmRNSResult of AGM
22nd Oct 20157:00 amRNSAGM Statement
15th Oct 20157:00 amRNSLevolux wins £3m order in the USA
23rd Sep 20154:50 pmRNSHolding(s) in Company
22nd Sep 20151:45 pmRNSHolding(s) in Company
9th Sep 20152:04 pmRNSHolding(s) in Company
8th Sep 20154:22 pmRNSHolding(s) in Company
7th Sep 20153:50 pmRNSHolding(s) in Company
3rd Sep 20157:00 amRNSAnnual Financial Report
1st Sep 20154:08 pmRNSHolding(s) in Company
13th Jul 20157:00 amRNSNotice of Results
6th Jul 20154:20 pmRNSHolding(s) in Company
26th Jun 20155:34 pmRNSDisposal of APC & Trading Update
2nd Apr 20152:03 pmRNSDirector/PDMR Shareholding
13th Mar 20152:10 pmRNSDirector/PDMR Shareholding
10th Mar 20159:42 amRNSDirector/PDMR Shareholding
2nd Mar 201512:48 pmRNSTR-1: Notification of Major Interest in Shares
13th Feb 20153:25 pmRNSDirector/PDMR Shareholding
3rd Feb 20157:00 amRNSHalf Yearly Report
14th Jan 20157:00 amRNSNotice of Results
21st Nov 20142:06 pmRNSTR1 Notification
30th Oct 20144:30 pmRNSResult of AGM
30th Oct 20147:00 amRNSInterim Management Statement
13th Oct 20141:46 pmRNSDirector/PDMR Shareholding
1st Oct 20148:00 amRNSDisposal
3rd Sep 20144:13 pmRNSHolding(s) in Company
2nd Sep 20147:01 amRNSFinal Results
2nd Sep 20147:00 amRNSDirectorate Change
8th Aug 20147:00 amRNSNotice of Results
24th Jun 20144:29 pmRNSDirector/PDMR Shareholding
16th May 20147:00 amRNSInterim Management Statement
11th Apr 20147:00 amRNSMajor Order
12th Mar 20144:19 pmRNSDirector/PDMR Shareholding
4th Feb 20147:00 amRNSInterim Results
8th Jan 20148:56 amRNSInterim Date Notification
24th Oct 20134:17 pmRNSResult of AGM
24th Oct 20137:00 amRNSInterim Management Statement
14th Oct 20133:21 pmRNSDirector/PDMR Shareholding
3rd Sep 20137:00 amRNSANNUAL RESULTS ANNOUNCEMENT
12th Jul 20137:00 amRNSTrading Statement
15th May 20137:00 amRNSInterim Management Statement
19th Mar 20134:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.